US FDA Approves Two Biosimilars for Blockbuster Eye Drug Eylea

The U.S. Food and Drug Administration (FDA) on Monday approved two close copies of Regeneron Pharmaceuticals' Eylea, its first-ever clearance to biosimilar versions of the...
Reuters Health Information